What is he best known for?
The fields of study he is best known for:
- Gene
- Internal medicine
- Enzyme
His scientific interests lie mostly in Molecular biology, Gene, Genetics, Internal medicine and Endocrinology.
His research integrates issues of Primary Hyperoxaluria Type I, X chromosome, Skewed X-inactivation, XIST and Signal peptide in his study of Molecular biology.
His Gene research is multidisciplinary, incorporating elements of Spermatogenesis and Testicular tissue.
In his research, Intron and Ameloblast is intimately related to Amelogenesis imperfecta, which falls under the overarching field of Genetics.
His research in the fields of Transplantation, Oxalobacter and Oxalate transport overlaps with other disciplines such as SLC26A6.
His study on Primary hyperoxaluria and Kidney is often connected to Gestation and Luteinizing hormone as part of broader study in Endocrinology.
His most cited work include:
- Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis (581 citations)
- The human enamel protein gene amelogenin is expressed from both the X and the Y chromosomes. (292 citations)
- PrimPol, an Archaic Primase/Polymerase Operating in Human Cells (215 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Internal medicine, Endocrinology, Molecular biology, Genetics and Gene.
His work investigates the relationship between Internal medicine and topics such as Gastroenterology that intersect with problems in Diabetes mellitus and Immunology.
His research on Endocrinology often connects related areas such as Receptor.
His research on Molecular biology also deals with topics like
- Complementary DNA that connect with fields like Intron,
- Somatic cell which intersects with area such as XIST.
His X chromosome, X-inactivation, Homology and Gene expression study in the realm of Gene interacts with subjects such as Steroid sulfatase.
His Kidney study integrates concerns from other disciplines, such as Epidermal growth factor and Pathology.
He most often published in these fields:
- Internal medicine (43.61%)
- Endocrinology (27.75%)
- Molecular biology (20.70%)
What were the highlights of his more recent work (between 2013-2021)?
- Internal medicine (43.61%)
- Biochemistry (8.81%)
- Primary hyperoxaluria (12.33%)
In recent papers he was focusing on the following fields of study:
His main research concerns Internal medicine, Biochemistry, Primary hyperoxaluria, Endocrinology and Gene.
His Internal medicine study combines topics from a wide range of disciplines, such as Gastroenterology, Diabetes mellitus and Oncology.
His Primary hyperoxaluria research is multidisciplinary, incorporating perspectives in Immunohistochemistry and Inborn error of metabolism.
His studies link Enzyme replacement therapy with Endocrinology.
His Gene study often links to related topics such as Cancer research.
His work carried out in the field of Mutation brings together such families of science as Phenotype and Molecular biology.
Between 2013 and 2021, his most popular works were:
- CRISPR/Cas9-mediated glycolate oxidase disruption is an efficacious and safe treatment for primary hyperoxaluria type I (122 citations)
- Inhibition of Glycolate Oxidase With Dicer-substrate siRNA Reduces Calcium Oxalate Deposition in a Mouse Model of Primary Hyperoxaluria Type 1 (46 citations)
- Glycolate Oxidase Is a Safe and Efficient Target for Substrate Reduction Therapy in a Mouse Model of Primary Hyperoxaluria Type I (41 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Internal medicine
- Enzyme
Eduardo Salido mainly investigates Biochemistry, Internal medicine, Glyoxylate cycle, Primary hyperoxaluria and Genetics.
Eduardo Salido has included themes like Cyclooxygenase and Endocrinology in his Internal medicine study.
The study incorporates disciplines such as Thromboxane and Fatty liver in addition to Endocrinology.
Eduardo Salido combines subjects such as Calcium oxalate, Kidney and Primary Hyperoxaluria Type I with his study of Glyoxylate cycle.
His Primary Hyperoxaluria Type I research integrates issues from Molecular biology, Glycolate oxidase, Allele and CRISPR.
His research investigates the link between Primary hyperoxaluria and topics such as Inborn error of metabolism that cross with problems in Peroxisome, Excretion, Clinical trial and Bioinformatics.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
